Compounds > 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Hyperesthesia

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Hyperesthesia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dallob, A; Goldenberg, MM; Guindon, Y1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Hyperesthesia

ArticleYear
Pharmacological evidence for a role of lipoxygenase products in platelet-activating factor (PAF)-induced hyperalgesia.
    Biochemical pharmacology, 1987, Oct-01, Volume: 36, Issue:19

    Topics: Animals; Dose-Response Relationship, Drug; Female; Hyperalgesia; Hyperesthesia; Leukotriene B4; Lipoxygenase; Platelet Activating Factor; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Inbred Strains

1987